Thurston Springer Miller Herd & Titak’s Eli Lilly LLY Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.96M	Buy	4,965 +1,512	+44%	+$1.54M	2.17%	4
2026 Q1	$3.18M	Sell	3,453 -4,324	-56%	-$4.38M	1.31%	6
2025 Q4	$8.36M	Buy	7,777 +7,055	+977%	+$6.75M	2.91%	3
2025 Q3	$552K	Sell	722 -18,349	-96%	-$13.7M	1.09%	9
2025 Q2	$14.9M	Buy	19,071 +1,862	+11%	+$1.45M	1.92%	6
2025 Q1	$14.2M	Buy	17,209 +4,124	+32%	+$3.43M	2.39%	5
2024 Q4	$10.1M	Buy	13,085 +2,642	+25%	+$2.19M	2.04%	6
2024 Q3	$9.25M	Buy	10,443 +11	+0.1%	+$9.89K	2.55%	5
2024 Q2	$9.45M	Buy	+10,432	New	+$8.34M	2.94%	3

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's LLY Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Eli Lilly (LLY) stake by 44% in Q2 2026, buying an estimated $1.54M and bringing the position to 4,965 shares worth $5.96M. The position accounts for 2.17% of the portfolio, ranked #4.

Thurston Springer Miller Herd & Titak first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $14.9M in Q2 2025. 1,841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Thurston Springer Miller Herd & Titak held 4,965 shares of Eli Lilly worth $5.96M as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 1,512 Eli Lilly shares in Q2 2026, an estimated $1.54M.
Eli Lilly made up 2.17% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #4 holding.
Thurston Springer Miller Herd & Titak first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's Eli Lilly position peaked at $14.9M in Q2 2025.
1,841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.